These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH. Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636 [Abstract] [Full Text] [Related]
3. Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation. Herre JM, Titus C, Oeff M, Eldar M, Franz MR, Griffin JC, Scheinman MM. Ann Intern Med; 1990 Nov 01; 113(9):671-6. PubMed ID: 2121082 [Abstract] [Full Text] [Related]
9. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia. Kuck KH, Kunze KP, Schlüter M, Duckeck W. Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166 [Abstract] [Full Text] [Related]
10. Encainide and flecainide: are they interchangeable? Saini V, Podrid PJ, Slater W, Lown B. Am Heart J; 1989 Jun 20; 117(6):1253-8. PubMed ID: 2499169 [Abstract] [Full Text] [Related]
12. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system. Stramba-Badiale M, Lazzarotti M, Facchini M, Schwartz PJ. Am Heart J; 1994 Nov 20; 128(5):973-82. PubMed ID: 7524295 [Abstract] [Full Text] [Related]